
|Videos|April 29, 2022
Improving vaccination rates in high-risk groups
Author(s)Miranda Hester
A look at a recently presented study on improving 23-valent pneumococcal polysaccharide vaccine uptake in groups that are at high risk.
Advertisement
Anthony W. Gannon, MD, a pediatric endocrinilogist at Nemours Children's in Wilmington, Delaware, sat down with Contemporary Pediatrics to discuss a poster presented at the 2022 Pediatric Academic Societies meeting that examined the impact of a quality improvement program on improving 23-valent pneumococcal polysaccharide vaccine uptake in 3 groups that are at high risk. He shared the ins and outs of the research, how other health systems could consider a similar project, and what the next steps are.
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Jamie Wood, MD, on the significance of the Afrezza approval for pediatric diabetes
2
How to recognize and when to refer for children with hidradenitis suppurativa
3
Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation
4
Simple screening questions may help pediatricians identify hidradenitis suppurativa earlier
5





